Addus HomeCare’s (ADUS) “Market Outperform” Rating Reaffirmed at JMP Securities

JMP Securities reiterated their market outperform rating on shares of Addus HomeCare (NASDAQ:ADUS) in a report issued on Thursday morning,Benzinga reports. They currently have a $150.00 price objective on the stock.

A number of other research analysts also recently issued reports on ADUS. Stephens restated an “overweight” rating and issued a $142.00 price objective on shares of Addus HomeCare in a research note on Wednesday, March 12th. Macquarie reaffirmed an “outperform” rating and set a $129.00 price target on shares of Addus HomeCare in a research report on Thursday, February 27th. Oppenheimer lifted their price objective on Addus HomeCare from $145.00 to $150.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. Citizens Jmp raised shares of Addus HomeCare to a “strong-buy” rating in a report on Monday, December 16th. Finally, StockNews.com downgraded shares of Addus HomeCare from a “buy” rating to a “hold” rating in a research note on Wednesday, February 26th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, seven have given a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, Addus HomeCare currently has a consensus rating of “Moderate Buy” and a consensus price target of $132.78.

Addus HomeCare Stock Up 0.8 %

Shares of NASDAQ:ADUS opened at $101.77 on Thursday. The stock has a market cap of $1.85 billion, a price-to-earnings ratio of 23.29, a PEG ratio of 1.41 and a beta of 0.93. The business’s 50 day moving average is $101.60 and its 200 day moving average is $118.29. Addus HomeCare has a 12-month low of $87.88 and a 12-month high of $136.72.

Addus HomeCare (NASDAQ:ADUS) last announced its earnings results on Monday, February 24th. The company reported $1.26 EPS for the quarter, missing the consensus estimate of $1.35 by ($0.09). The firm had revenue of $297.14 million during the quarter, compared to analysts’ expectations of $291.04 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. As a group, equities research analysts expect that Addus HomeCare will post 4.59 earnings per share for the current year.

Institutional Trading of Addus HomeCare

Several hedge funds have recently added to or reduced their stakes in ADUS. Capital Research Global Investors bought a new position in shares of Addus HomeCare during the fourth quarter valued at about $51,149,000. American Century Companies Inc. boosted its holdings in Addus HomeCare by 695.8% during the 4th quarter. American Century Companies Inc. now owns 284,346 shares of the company’s stock valued at $35,643,000 after acquiring an additional 248,613 shares during the period. GAMMA Investing LLC grew its position in Addus HomeCare by 10,307.8% during the 1st quarter. GAMMA Investing LLC now owns 130,930 shares of the company’s stock worth $12,948,000 after acquiring an additional 129,672 shares during the last quarter. Bank of America Corp DE increased its stake in Addus HomeCare by 273.6% in the 4th quarter. Bank of America Corp DE now owns 175,070 shares of the company’s stock worth $21,945,000 after purchasing an additional 128,211 shares during the period. Finally, TimesSquare Capital Management LLC lifted its position in Addus HomeCare by 28.5% in the fourth quarter. TimesSquare Capital Management LLC now owns 355,750 shares of the company’s stock valued at $44,593,000 after purchasing an additional 78,835 shares during the last quarter. 95.35% of the stock is owned by institutional investors.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.